Dan T Stinchcomb

USPTO Granted Patents = 57 (Patent Applications = 9)

EPO Patents = 10 (Patent Applications = 13)

Average Co-Inventor Count = 3.8

ph-index = 13

Forward Citations = 712(Granted Patents)

Forward Citations (Not Self Cited) = 691(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Boulder, CO (US) (1997 - 2002)
Ft. Collins, CO (US) (2000 - 2006)
Fort Collins, CO (US) (1998 - 2021)
Enumclaw, WA (US) (2018 - 2024)

Company Filing History:

24 out of 69

Takeda Vaccines, Inc.

patents

19 out of 110

Ribozyme Pharmaceuticals, Incorporated

patents

6 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

Igm Biosciences, Inc.

Sirna Therapeutics, Inc.

Warner-lambert Company

patents

11. 5 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...

57 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12186363 - Compositions and methods for dengue virus chimeric constructions in vaccines (2025-01-07),

2. 11931399 - Compositions and methods for dengue virus chimeric constructions in vaccines (2024-03-19),

3. 11197923 - Methods and compositions for live attenuated viruses (2021-12-14),

4. 11192941 - Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof (2021-12-07),

5. 10898565 - Compositions, methods and uses for dengue virus serotype-4 constructs (2021-01-26),

6. 10806782 - Hand, foot, and mouth vaccines and methods of manufacture and use thereof (2020-10-20),

7. 10806781 - Compositions and methods for live, attenuated alphavirus formulations (2020-10-20),

8. 10570191 - Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof (2020-02-25),

9. 10525120 - Methods and compositions for live attenuated viruses (2020-01-07),

10. 10449231 - Compositions and methods for dengue virus chimeric constructs in vaccines (2019-10-22),

11. 10233429 - Hand, foot, and mouth vaccines and methods of manufacture and use thereof (2019-03-19),

12. 10137186 - Compositions and methods for live, attenuated alphavirus formulations (2018-11-27),

13. 10052374 - Compositions, methods and uses for dengue virus serotype-4 constructs (2018-08-21),

14. 10010600 - Compositions and methods for administration of vaccines against dengue virus (2018-07-03),

15. 9890362 - Compositions, methods and uses for inducing viral growth (2018-02-13),

Title: Dan T Stinchcomb - Pioneering Inventor from Boulder, CO

Introduction: Dan T Stinchcomb is a renowned inventor hailing from Boulder, Colorado, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Dan T Stinchcomb holds several patents in the areas of biotechnology, medical devices, and renewable energy, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, Stinchcomb has worked with leading research institutions and companies, consistently pushing the boundaries of technology and science. His inventions have revolutionized the way we approach healthcare, sustainability, and beyond.

Collaborations: Throughout his career, Dan T Stinchcomb has collaborated with top universities, cutting-edge companies, and brilliant minds in the industry. These collaborations have not only led to remarkable inventions but have also paved the way for future innovations.

Conclusion: Dan T Stinchcomb's passion for innovation, coupled with his relentless drive to make a difference, has solidified his position as a trailblazing inventor in the world of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.